United States Pharmaceuticals

Acucela Inc (4589)

Track

Ticker: 4589 Exchange: TYO
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 17 Jul 2017
Value US$4,967,705.18 | Price 283.59 | Shares 69,470 (-49.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-07-18 2017-07-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
69,470 -49.6%
283.59
US$4,967,705 		69,470 -49.6% 283.59 US$4,967,705
2017-07-05 2017-07-05 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
78,806 -34.2%
30.47
US$3,733,191 		78,806 -34.2% 30.47 US$3,733,191
2017-07-05 2017-07-05 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
97,564 -28.0%
75.61
US$2,556,502 		97,564 -28.0% 75.61 US$2,556,502
2017-06-20 2017-06-20 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,300 -11.8%
6.95
US$9,035 		1,300 -11.8% 6.95 US$9,035
2017-06-02 2017-06-01 S Sale GEBHART JOHN E

Chief Financial Officer
3,380 -7.7%
7.38
US$24,944 		3,380 -7.7% 7.38 US$24,944
2017-06-02 2017-06-01 S Sale
DANSE EDWARD H

Chief Business Officer
1,080 -1.5%
7.38
US$7,970 		1,080 -1.5% 7.38 US$7,970
2017-05-18 2017-05-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
1,275 -13.3%
6.15
US$7,841 		1,275 -13.3% 6.15 US$7,841
2017-05-02 2017-05-01 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
3,615 -9.1%
6.15
US$22,232 		3,615 -9.1% 6.15 US$22,232
2017-05-02 2017-05-01 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,100 -1.5%
6.15
US$6,765 		1,100 -1.5% 6.15 US$6,765
2017-04-17 2017-04-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,320 -16.0%
6.48
US$8,554 		1,320 -16.0% 6.48 US$8,554
2017-04-04 2017-04-04 S Sale GEBHART JOHN E

Chief Financial Officer
3,400 -9.5%
6.75
US$22,950 		3,400 -9.5% 6.75 US$22,950
2017-04-04 2017-04-04 S Sale DANSE EDWARD H

Chief Business Officer
1,100 -1.5%
6.75
US$7,425 		1,100 -1.5% 6.75 US$7,425
2017-03-20 2017-03-20 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,250 -18.3%
7.10
US$8,875 		1,250 -18.3% 7.10 US$8,875
2017-03-02 2017-03-02 S Sale GEBHART JOHN E

Chief Financial Officer
3,550 -11.1%
7.70
US$27,335 		3,550 -11.1% 7.70 US$27,335
2017-03-02 2017-03-02 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,250 -1.7%
7.72
US$9,650 		1,250 -1.7% 7.72 US$9,650
2017-02-21 2017-02-17 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,450 -25.7%
8.10
US$11,745 		1,450 -25.7% 8.10 US$11,745
2017-02-03 2017-02-02 S Sale GEBHART JOHN E

Chief Financial Officer
3,875 -13.7%
8.60
US$33,325 		3,875 -13.7% 8.60 US$33,325
2017-02-03 2017-02-02 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,250 -1.6%
8.50
US$10,625 		1,250 -1.6% 8.50 US$10,625
2017-02-08 2017-01-23 B Purchase SBI Holdings, Inc. Large shareholder
17,200 +0.2%
150,643.21
US$2,591,063,212 		17,200 +0.2% 150,643.21 US$2,591,063,212
2017-02-08 2017-01-20 B Purchase SBI Holdings, Inc. Large shareholder
12,900 +0.2%
111,884.33
US$1,443,307,857 		12,900 +0.2% 111,884.33 US$1,443,307,857
2017-02-08 2017-01-19 B Purchase SBI Holdings, Inc. Large shareholder
100 +0.0%
869.60
US$86,960 		100 +0.0% 869.60 US$86,960
2017-01-20 2017-01-18 S Sale SCHEIBLER LUKAS

EVP of Research & Development
1,475 -33.2%
8.70
US$12,832 		1,475 -33.2% 8.70 US$12,832
2017-02-08 2017-01-12 B Purchase SBI Holdings, Inc. Large shareholder
7,100 +0.1%
63,447.32
US$450,475,972 		7,100 +0.1% 63,447.32 US$450,475,972
2017-01-06 2017-01-04 S Sale GEBHART JOHN E

Chief Financial Officer
3,790 -15.4%
8.58
US$32,518 		3,790 -15.4% 8.58 US$32,518
2017-01-06 2017-01-04 S Sale
DANSE EDWARD H

Chief Business Officer

Officer
1,270 -1.6%
8.58
US$10,897 		1,270 -1.6% 8.58 US$10,897
2017-01-10 2016-12-30 B Purchase SBI Holdings, Inc. Large shareholder
2,700 +0.0%
22,970.05
US$62,019,135 		2,700 +0.0% 22,970.05 US$62,019,135
2017-01-10 2016-12-29 B Purchase SBI Holdings, Inc. Large shareholder
16,900 +0.2%
143,507.13
US$2,425,270,497 		16,900 +0.2% 143,507.13 US$2,425,270,497
2017-01-10 2016-12-28 B Purchase SBI Holdings, Inc. Large shareholder
204,800 +2.6%
1,735,239.23
US$355,376,994,304 		204,800 +2.6% 1,735,239.23 US$355,376,994,304
2016-12-27 2016-12-22 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
880 -33.0%
8.18
US$7,198 		880 -33.0% 8.18 US$7,198
2016-12-27 2016-12-22 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
3,210 -15.8%
8.18
US$26,258 		3,210 -15.8% 8.18 US$26,258
2016-12-19 2016-12-15 S Sale DANSE EDWARD H

Chief Business Officer

Officer
1,090 -1.4%
8.75
US$9,538 		1,090 -1.4% 8.75 US$9,538
2016-11-21 2016-11-21 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
2,663 -100.0%
9.35
US$24,891 		2,663 -100.0% 9.35 US$24,891
2016-11-15 2016-11-14 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
1,774 -100.0%
9.44
US$16,745 		1,774 -100.0% 9.44 US$16,745
2016-09-30 2016-09-29 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
9,000 -68.2%
13.09
US$117,830 		9,000 -68.2% 13.09 US$117,830
2016-09-20 2016-09-20 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
2,663 -100.0%
9.53
US$25,382 		2,663 -100.0% 9.53 US$25,382
2016-09-12 2016-09-12 S Sale GEBHART JOHN E

Chief Financial Officer

Officer
60,000 -82.0%
9.86
US$591,420 		60,000 -82.0% 9.86 US$591,420
2016-09-02 2016-08-31 S Sale DANSE EDWARD H

Chief Business Officer

Officer
25,013 -23.5%
10.04
US$251,131 		25,013 -23.5% 10.04 US$251,131
2016-08-18 2016-08-18 S Sale SCHEIBLER LUKAS

EVP of Research & Development

Officer
31,962 -100.0%
10.81
US$345,509 		31,962 -100.0% 10.81 US$345,509
2016-08-18 2016-08-18 S Sale DANSE EDWARD H

Chief Business Officer

Officer
75,101 -41.4%
10.81
US$811,842 		75,101 -41.4% 10.81 US$811,842
2016-07-21 2016-06-27 B Purchase SBI Holdings, Inc. Large shareholder
617,800 +8.3%
22.15
US$13,684,270 		617,800 +8.3% 22.15 US$13,684,270
2016-07-21 2016-06-24 B Purchase SBI Holdings, Inc. Large shareholder
478,600 +6.9%
17.67
US$8,456,862 		478,600 +6.9% 17.67 US$8,456,862
2016-07-21 2016-06-23 B Purchase SBI Holdings, Inc. Large shareholder
991,000 +16.7%
19.05
US$18,878,550 		991,000 +16.7% 19.05 US$18,878,550
2016-07-21 2016-06-22 B Purchase SBI Holdings, Inc. Large shareholder
456,400 +8.3%
16.21
US$7,398,244 		456,400 +8.3% 16.21 US$7,398,244
2016-07-21 2016-06-21 B Purchase SBI Holdings, Inc. Large shareholder
555,000 +11.3%
16.13
US$8,952,150 		555,000 +11.3% 16.13 US$8,952,150
2016-07-21 2016-06-20 B Purchase SBI Holdings, Inc. Large shareholder
723,200 +17.2%
16.03
US$11,592,896 		723,200 +17.2% 16.03 US$11,592,896
2016-07-21 2016-06-17 B Purchase SBI Holdings, Inc. Large shareholder
776,300 +22.6%
12.53
US$9,727,039 		776,300 +22.6% 12.53 US$9,727,039
2016-07-21 2016-06-16 B Purchase SBI Holdings, Inc. Large shareholder
257,000 +8.1%
11.13
US$2,860,410 		257,000 +8.1% 11.13 US$2,860,410
2016-07-21 2016-06-15 B Purchase SBI Holdings, Inc. Large shareholder
1,018,400 +47.3%
9.30
US$9,471,120 		1,018,400 +47.3% 9.30 US$9,471,120
2016-07-21 2016-06-03 B Purchase SBI Holdings, Inc. Large shareholder
256,300 +13.5%
9.63
US$2,468,169 		256,300 +13.5% 9.63 US$2,468,169
2016-07-21 2016-06-02 B Purchase SBI Holdings, Inc. Large shareholder
342,500 +22.0%
10.08
US$3,452,400 		342,500 +22.0% 10.08 US$3,452,400
2014-08-27 2014-08-26 S Sale DEYOUNG HIEN

VP Human Resources

Officer
56,800 -100.0%
7.89
US$448,152 		56,800 -100.0% 7.89 US$448,152
2014-08-19 2014-08-18 S Sale Lowrance David L

CFO, Secretary, Treasurer

Officer
40,500 -100.0%
7.05
US$285,525 		40,500 -100.0% 7.05 US$285,525
2014-03-17 2014-03-13 S Sale KUBOTA RYO

CEO, President and COB

Executive Director Large shareholder
1,380,000 -11.9%
16.02
US$22,107,600 		1,380,000 -11.9% 16.02 US$22,107,600
Explore more

More insider trading research around Acucela Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America